Bone Mineral Density News and Research

RSS

Merck announces results from odanacatib Phase II trial on post-menopausal osteoporosis

Merck, known as MSD outside the United States and Canada, today announced results from a Phase II trial for odanacatib, an investigational cathepsin K (cat-K) inhibitor in development for the treatment of osteoporosis in post-menopausal women.

15 Oct 2012

Vitamin C actively protects against osteoporosis

Researchers at Mount Sinai School of Medicine have shown for the first time in an animal model that vitamin C actively protects against osteoporosis, a disease affecting large numbers of elderly women and men in which bones become brittle and can fracture. The findings are published in the October 8 online edition of PLoS ONE.

10 Oct 2012

Five researchers receive IOF Young Investigator Awards

Five researchers were presented with 'IOF Young Investigator Awards' at the International Osteoporosis Foundation (IOF) Regionals - 2nd Middle East & Africa Osteoporosis Meeting and the 6th Pan Arab Osteoporosis Congress PAOC'6 on September 30, 2012.

2 Oct 2012

UAB urges women to get tested for key measures throughout their lives

Heart disease, cancer and stroke are the leading causes of death in women of all ages in the United States, according to the Centers for Disease Control and Prevention. To get ahead of these chronic health issues and possibly prevent them from worsening, experts at the University of Alabama at Birmingham urge women to get tested for key measures throughout their lives.

21 Sep 2012

Alcohol refrain for bone density gain

Abstinence from alcohol for 2 months could correct the imbalance between bone formation and resorption in alcoholic men, a study shows.

21 Sep 2012

Amgen receives FDA approval for Prolia to treat bone loss in men with osteoporosis

Amgen today announced the U.S. Food and Drug Administration (FDA) approved a new indication for Prolia (denosumab) as a treatment to increase bone mass in men with osteoporosis at high risk for fracture.

21 Sep 2012

Alendronate decreases BMD loss in prostate cancer

Weekly administration of oral biphosphonate alendronate could reduce loss of bone mineral density in prostate cancer patients who start androgen-deprivation therapy, show study findings.

19 Sep 2012

$Simple interventions boost vertebral fracture osteoporosis care$

Simple interventions boost vertebral fracture osteoporosis care

Use of osteoporosis investigation and treatment is significantly increased in older patients with asymptomatic vertebral fracture by use of physician- and patient-targeted interventions, Canadian research suggests.

7 Sep 2012

IOF publishes practical guidelines to help doctors assess patient response to osteoporosis treatment

The International Osteoporosis Foundation (IOF) has published practical guidelines to assist clinicians in assessing treatment efficacy in patients who experience a fracture while on medication for osteoporosis.

1 Sep 2012

FDA approves Gilead’s Stribild to treat HIV-1 infection

The U.S. Food and Drug Administration today approved Stribild (elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate), a new once-a-day combination pill to treat HIV-1 infection in adults who have never been treated for HIV infection.

28 Aug 2012

Gilead Sciences receives FDA approval for Stribild to treat HIV-1 infection

Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Stribild (elvitegravir 150 mg/cobicistat 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), a complete once-daily single tablet regimen for HIV-1 infection for treatment-naïve adults.

28 Aug 2012

Diet and exercise help protect astronauts' bones in space

Eating the right diet and exercising hard in space helps protect International Space Station astronauts' bones, a finding that may help solve one of the key problems facing future explorers heading beyond low Earth orbit.

27 Aug 2012

Physical activity effective in reducing sclerostin in premenopausal women

A study to be published in the Endocrine Society's Journal of Clinical Endocrinology and Metabolism (JCEM) suggests that physical activity for premenopausal women is very effective in reducing sclerostin-a known inhibitor of bone formation. In addition, physical training enhances IGF-1levels, which have a very positive effect on bone formation.

16 Aug 2012

Therapeutic breaks for prostate cancer patients

Men with advanced prostate cancer receiving androgen-deprivation therapy may be better off being treated intermittently rather than on a continuous basis, show study findings.

15 Aug 2012

Calcium and vitamin D supplements do not prevent bone loss in men with prostate cancer

Prescribing calcium and vitamin D supplements for men at risk of bone loss from hormonal treatment for prostate cancer seems like good medicine.

8 Aug 2012

Child abuse has repercussions for menarche

Researchers have found an association between childhood abuse and age at menarche onset, they report in the Journal of Adolescent Health.

3 Aug 2012

Alcohol decreases turnover of bone in post-menopausal women

Women after menopause tend to develop weaker bones from what is known as osteoporosis, which may lead to fractures (especially hip fractures) from falling. The weakness of the bones results from an imbalance between the normal resorption (a type of dissolving of old bone) and the laying down of new bone, an ongoing process for both men and women referred to as "bone turnover."

3 Aug 2012

Childhood physical and sexual abuse may increase risk of early or late onset menarche

Researchers from Boston University School of Medicine (BUSM) have found an association between childhood physical and sexual abuse and age at menarche.

28 Jul 2012

Gilead receives FDA approval for Truvada to reduce risk of sexually acquired HIV-1 infection

Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved once-daily oral Truvada (emtricitabine and tenofovir disoproxil fumarate), in combination with safer sex practices, to reduce the risk of sexually acquired HIV-1 infection in adults at high risk.

17 Jul 2012

Rehabilitation after rotator cuff surgery may be partially to blame for high rates of failed healing

A new Hospital for Special Surgery study suggests that the current rehabilitation used for patients undergoing tendon-bone repairs such as rotator cuff repair may be partially to blame for the high rates of failed healing after surgery. Experiments in a rat model of this injury suggest that immobilizing the limb for four to six weeks after surgery, rather than quickly starting physical therapy, improves healing.

16 Jul 2012

Bone Mineral Density News and Research

Merck announces results from odanacatib Phase II trial on post-menopausal osteoporosis

Vitamin C actively protects against osteoporosis

Five researchers receive IOF Young Investigator Awards

UAB urges women to get tested for key measures throughout their lives

Alcohol refrain for bone density gain

Amgen receives FDA approval for Prolia to treat bone loss in men with osteoporosis

Alendronate decreases BMD loss in prostate cancer

Simple interventions boost vertebral fracture osteoporosis care

IOF publishes practical guidelines to help doctors assess patient response to osteoporosis treatment

FDA approves Gilead’s Stribild to treat HIV-1 infection

Gilead Sciences receives FDA approval for Stribild to treat HIV-1 infection

Diet and exercise help protect astronauts' bones in space

Physical activity effective in reducing sclerostin in premenopausal women

Therapeutic breaks for prostate cancer patients

Calcium and vitamin D supplements do not prevent bone loss in men with prostate cancer

Child abuse has repercussions for menarche

Alcohol decreases turnover of bone in post-menopausal women

Childhood physical and sexual abuse may increase risk of early or late onset menarche

Gilead receives FDA approval for Truvada to reduce risk of sexually acquired HIV-1 infection

Rehabilitation after rotator cuff surgery may be partially to blame for high rates of failed healing

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News